Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06040697 · ClinicalTrials.gov registry record
Formative Usability Assessment of Wireless Thermal Anisotropy Devices
A clinical trial of Hydrocephalus, sponsored by Rhaeos.
- Recruiting
- Registry status
- 145
- Enrollment target
- 1
- Study location
NCT06040697: Recruiting study of Hydrocephalus, sponsored by Rhaeos.
NCT06040697 is a study of Hydrocephalus that is actively recruiting participants, run by Rhaeos. The registered enrollment target is 145 participants, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06040697, a study of Hydrocephalus, is actively recruiting participants, sponsored by Rhaeos.
- RECRUITING
- Registry status
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
Measurements of shunt flow will be performed non-invasively. This study will generate usability data via observed tasks and comprehension questions to enable future device design improvements.
Primary Outcome
Identification of usability risks \[unscored\]
Conditions Studied
Interventions
- DEVICE Thermal Anisotropy
Study Locations (1)
Illinois
- Rhaeos, Inc. - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2023-09-29 |
| Est. Completion | 2025-12 |
What NCT06040697 shows while recruiting
NCT06040697 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (16% higher).
The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which Thermal Anisotropy is the first listed.
NCT06040697 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06040697 about?
NCT06040697 is a clinical study titled "Formative Usability Assessment of Wireless Thermal Anisotropy Devices". Measurements of shunt flow will be performed non-invasively. This study will generate usability data via observed tasks and comprehension questions to enable future device design improvements.
What is the current status of trial NCT06040697?
This trial is currently recruiting. The enrollment target is 145 participants. The study started on 2023-09-29. Estimated completion is 2025-12.
What conditions does trial NCT06040697 study?
This clinical trial studies the following conditions: Hydrocephalus.
What interventions are being tested in trial NCT06040697?
The interventions under investigation include: Thermal Anisotropy (DEVICE).
Who is sponsoring clinical trial NCT06040697?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06040697 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06040697's enrollment target sits among peer trials
145 4th of 17 higher than 14 of 17 other Hydrocephalus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hydrocephalus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NIRS Monitoring in Premature Infants
RECRUITING
-
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
RECRUITING · NA
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
RECRUITING · NA
-
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
RECRUITING · NA
-
CoMind Early Feasibility Study
RECRUITING
-
Flow Detection in Open and Closed Shunt Valve Periods
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI